Under construction – not a live service
Sign in
Not yet taking people in Puerto RicoNo phase

Direct-to-angio Approach From loCal hOspitals Based on a PoInt-of-care bLOod Test for LVO

Key facts

Where
Caguas, Puerto RicoSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 21 and 85 years old?

Source: NCT06910163, who can take part

Where in Puerto Rico

  • Hospital Menonita CaguasCaguas, Puerto RicoNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Juan Vicenty
Trial code
NCT06910163
Record updated
4 April 2025
Original description
Direct-to-angio approach from loCal hOspitals based on a PoInt-of-care bLOod Test for LVO (COPILOT) is a multi-center, prospective, cluster-randomized crossover trial that will evaluate if the triage assessment to thrombectomy puncture time is shorter after performing the LVOne testing compared to current management standards in patients with suspected large vessel occlusion.Read full original descriptionShow less

Direct-to-angio Approach From loCal hOspitals Based on a PoInt-of-care bLOod Test for LVO (COPILOT): an Effectiveness Cluster Randomized Crossover Trial

Direct-to-angio approach from loCal hOspitals based on a PoInt-of-care bLOod Test for LVO (COPILOT) is a multi-center, prospective, cluster-randomized crossover trial that will evaluate if the triage assessment to thrombectomy puncture time is shorter after performing the LVOne testing compared to current management standards in patients with suspected large vessel occlusion.

Inclusion: Age: 21 to 85 years old; Language: Speak and understand Spanish or English; Residence: Resident of Puerto Rico; Clinical presentation: Suspected acute stroke; Time of presentation: Monday to Friday, between 8:00 a.m. and 4:00 p.m; Time of symptom onset: symptoms are known to have begun within the last 6 hours, OR last known to be well between 6 and 18 hours ago, confirmed by a reliable witness or healthcare professional.

Exclusion: Previous healthcare encounter:; Received thrombolysis therapy before consent (e.g., tPA, alteplase); Medical History: diagnosed with any of the following in the past 4 weeks: deep vein thrombosis (DVT), pulmonary embolism (PE), arterial embolism, stroke, transient ischemic attack (TIA), long bone fracture, major trauma, surgery under general anesthesia, or head injury requiring hospital admission within the last 4 weeks; Modified Rankin Scale: Pre-stroke mRS ≥ 3; Already assessed at another hospital, and ambulance admission is a transfer for continuing care OR; The patient is a pregnant woman; The patient is under legal custody or deprived of liberty in penitentiary institutions; The patient is unable to provide informed consent on their own and whose authorized legal representatives are unavailable in person or by telephone during recruitment.

ClinicalTrials.gov NCT06910163